What Multiple Are Buyers Actually Paying for Dental Practices in 2026?

Two general practices can hand a buyer the same $1 million of adjusted EBITDA and walk away $3 million apart at closing. Neither one is better run than the other. One is simply classified as a platform and the other as an add-on, and that classification was decided long before either owner picked up the phone.

Here's the claim we'll defend, and plenty of owners will hate it: you don't negotiate your multiple, you qualify for it. The size of your adjusted EBITDA and the composition of your payer mix set the band. Everything else your consultant is selling you as "multiple-enhancing" moves the number by half a turn at most, and often by nothing at all, because the buyer already knows what tier you're in before the first site visit. Our view: the multiple is a size question with a payer-mix modifier, not a quality question.

The 2026 Bands, and Where the Real Cliff Sits

Start with what buyers are actually paying. Sorso's 2026 valuation data puts practices under $1 million of adjusted EBITDA at 5 to 7 times, $1 million to $3 million at 7 to 9 times, $3 million to $5 million at 9 to 11 times, and $5 million and up at 11 times or better. Platform deals land at 9 to 11 times while add-ons clear 5 to 8, and specialty practices carry a premium of one to three additional turns.

Dental Transitions' 2026 DSO guide reads nearly the same: single-doctor add-ons under $1 million of EBITDA at 5 to 8 times, $1 million to $3 million at 7 to 9, $3 million to $5 million at 9 to 11, and platform-grade groups above $5 million at 10 to 12 times or higher. Two independent sources, one structure. That consistency is the point. The bands are not a negotiating range. They're a sorting mechanism.

Now do the arithmetic owners skip. A strong solo general practice runs an adjusted EBITDA margin somewhere between 18% and 26% of collections after a market-rate associate replaces the owner's clinical production. To reach $1 million of adjusted EBITDA at a 26% margin, you need roughly $3.8 million in collections. At a more typical 18%, you need about $5.6 million.

That is the cliff. The jump from the 5-to-8x band to the 7-to-9x band isn't a reward for tight systems or a beautiful operatory. It's a reward for having three to five practices' worth of collections under one tax ID. Almost no single location in America gets there.

$1.2M in Collections, $318,000 in EBITDA, and a $636,000 Argument

Take a specific practice. Four doctors' worth of nobody: one owner, one hygiene department, $1.2 million in collections. The owner personally produces $780,000 of it; hygiene and a part-time associate cover the remaining $420,000.

Operating expenses, excluding anything paid to the owner: staff and payroll taxes at $300,000, clinical supplies and lab at $144,000, facility at $84,000, and admin, marketing, insurance and software at $120,000. Total $648,000, or 54% of collections.

A buyer then subtracts what it costs to replace the owner clinically. At 30% of the owner's production, that's $234,000. Adjusted EBITDA comes to $318,000, a 26.5% margin.

At the bottom of the add-on band, 5 times, that practice is worth $1,590,000. At the top, 7 times, it's $2,226,000. The spread is $636,000 on an identical set of books.

So where in the band you land is worth more than two years of collections' worth of net income to you. That part is genuinely negotiable, and it's where owners should spend their energy. What is not negotiable is the band itself. Adding $150,000 of hygiene production to this practice at a 26.5% drop-through adds about $40,000 of EBITDA. At 6 times, that's $238,500 of enterprise value, which is real money and worth doing. It does not move you into the 7-to-9x tier. You'd need to add $2.6 million in collections for that.

What Most Owners Get Wrong: Quoting a Group's Multiple on a Solo's Books

The mistake is specific and it's expensive. An owner in their late fifties hears at a study club that a five-location group down the highway sold at 9.5 times. They go home, pull their tax return, see $420,000 of net income, multiply by 9.5, and start telling their spouse the practice is worth $4 million.

Two errors stacked on each other. First, the 9.5 times belonged to a different band: that group had $3 million of EBITDA and was priced as platform-grade. Second, the $420,000 of net income on a Schedule C or an S-corp return is not adjusted EBITDA. It still contains the owner's clinical earnings. Strip out a market-rate associate to do that dentistry and the number falls by $200,000 or more. Apply the correct band to the correct number and the practice that was "worth $4 million" is a $1.6 million to $2.2 million asset.

We've watched owners turn down clean doctor-buyer offers while waiting for a DSO number that was never coming, then come back to market eighteen months later with declining collections and a worse story. If your adjusted EBITDA is under $500,000, the DSO conversation is a 5-to-8x conversation, full stop. We'd take the strong doctor-buyer deal in that situation and stop auditioning for a tier you don't qualify for.

Medicaid at 50% Costs You $445,000 on This Deal

The one lever that moves real turns, short of tripling your size, is who pays you. Dental Transitions reports that Medicaid exposure above 50% of revenue can compress valuation by 15% to 25%, while a fee-for-service mix above 60% pushes a practice to the upper end of its band.

Run it against our $318,000 practice. Priced at 7 times, it's a $2,226,000 asset. Apply a 20% payer-mix compression and it's $1,780,800. That's $445,200 of value, gone, on volume you worked just as hard to produce.

Buyers aren't being moralistic about it. They're pricing reimbursement risk, legislative risk and the labor cost of the administrative load. A practice at 60% fee-for-service gets the benefit of the doubt in diligence because its revenue doesn't depend on a state budget line. A practice at 55% Medicaid gets a haircut and a longer earn-out.

This is the one place where three years of deliberate work actually changes your band position rather than your spot inside it. Dropping two bottom-quartile PPO plans and rebuilding that chair time at fee-for-service rates is slow, uncomfortable, and worth more at exit than any equipment purchase you'll make.

Why Buyers Have 1,032 Reasons Not to Stretch

Owners negotiate as if they're the only option on the table. They aren't. According to The Dental Signal Practice Market Index, built from active broker listings, there are 1,032 practices listed for sale right now. Median collections among them run $991,000, with the middle half between $659,842 and $1,500,000 (n=847). General practices look nearly identical at a $956,572 median (n=727). Median operatory count is 5 (n=847), and collections per operatory run a $200,000 median (n=724).

Read that as a description of the asking side of the market, not of all practices. What it tells you is that the shelf is stocked almost entirely with single-location practices around the $1 million mark, which is to say the shelf is stocked almost entirely with add-ons. A buyer looking to fill out a region doesn't need your practice. They need one of several hundred like it, and they know how many there are.

That's the backdrop to the demand story too. ADA Health Policy Institute analysis of nearly 200,000 practicing dentists found more than one in four dentists within ten years of graduation were affiliated with a DSO in 2024. Consolidation is real and buyer appetite is real. It just doesn't translate into competitive tension for a $300,000-EBITDA single site when there are a thousand comparable listings.

The Two Honest Ways to Jump a Band

If you want out of the add-on tier, there are exactly two routes, and both take years.

• Get specialty revenue inside the entity. Specialty practices carry a one-to-three-turn premium, per Sorso. Two extra turns on $318,000 of EBITDA is $636,000. Bringing an ortho or an oral surgeon in as a partner-producer, with that revenue running through your books rather than a separate LLC, changes what you're selling.
• Become the platform instead of the add-on. Platform deals price at 9 to 11 times against add-ons at 5 to 8. Getting there means acquiring two or three practices yourself, surviving the integration, and presenting a group with shared management infrastructure and $1 million-plus of EBITDA. That is a second career, not an exit strategy, and most owners over 58 should not start it.

For everyone else, the honest play is to maximize position inside your band: clean books with three years of consistent adjusted EBITDA, no owner-dependency in the hygiene schedule, a documented associate already producing, a lease with runway, and a payer mix you're not apologizing for. That's the $636,000 fight, and it's winnable.

Before You Take a Single Buyer Call This Week

Pull your last three years of tax returns and calculate adjusted EBITDA properly: net income, add back interest, depreciation, personal expenses and owner compensation, then subtract a real market-rate associate at 30% of your clinical production. Write down the number, find your band in the tables above, and multiply. Then pull your payer mix report and calculate what percentage of revenue came from Medicaid and what percentage came from fee-for-service, because that single ratio decides whether you sit at the top or the bottom of your band. If the band number is smaller than the retirement number, you have a strategy problem, not a negotiation problem, and the time to find that out is three years before you list, not three weeks after.

What we're watching into 2027: whether the platform bands hold at 10 to 12 times as debt costs stay elevated, and whether that thousand-listing backlog starts dragging the add-on floor below 5 times. We'd change our mind on the "you qualify, you don't negotiate" thesis if we start seeing sub-$1 million EBITDA single sites clearing 8 times with any consistency. So far, we haven't.

If you want to see where your own practice lands before a broker tells you, build the adjusted EBITDA yourself and apply the band. Our valuation calculator does that math on your actual collections, overhead and owner production, so you walk into the conversation knowing your tier instead of hearing it. Run your own numbers, then compare the output to the asking side of the market before you decide what your practice is worth.